Different mechanisms in the tumorigenesis of proximal and distal colon cancers

Current Opinion in Oncology

Volumn 13, Issue 1, 2001, Pages 63-69

  Lindblom, Annika ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOMATOUS POLYP; CANCER RISK; CARCINOGENESIS; CHROMOSOME FRAGILITY; COLORECTAL TUMOR; DIFFERENTIAL DIAGNOSIS; DNA METHYLATION; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; GENE MUTATION; GENETIC STABILITY; HUMAN; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

ADENOMATOUS POLYPOSIS COLI; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME FRAGILITY; COLON; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; HUMANS; MICROSATELLITE REPEATS; MUTATION;

EID: 0035171887     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200101000-00013     Document Type: Review

References (86)

1. The hallmarks of cancer
2. Carcinogenesis and natural selection: A new perspective to the genetics and epigenetics of colorectal cancer
3. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog
4. Genetic instabilities in human cancers
5. DNA methylation and genetic instability in colorectal cancer cells
6. Cancer cytogenetics
7. Mutations of mitotic checkpoint genes in human cancers
8. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
9. Microsatellite instability in cancer of the proximal colon
10. Clues to pathogenesis of familial colorectal cancer
11. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer
12. Hypermutability and mismatch repair deficiency in RER+ tumor cells
13. Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation
14. Eukaryotic DNA mismatch repair
15. A National Cancer Institute Workshop on microsatellite instability for cancer detection and familial predisposition: Development of international criteria for the determination of microsatellite instability in colorectal cancer
16. A genetic model for colorectal tumorigenesis
17. APC mutations in colorectal tumors with mismatch repair deficiency
18. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer
19. Alternative genetic pathways in colorectal carcinogenesis
20. Different genetic pathways to proximal and distal colorectal cancer influenced by sex related factors
21. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumors
22. Colorectal cancer with and without microsatellite instability involves different genes
23. Mutational analysis of the APC/B-catenin/Tcf pathway in colorectal cancer
24. Apoptosis induced by overexpression of hMSH2 and hMLH1
25. Involvement of the mismatch repair system in temozolomide-induced apoptosis
26. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
27. hMutSalpha- and hMutLalpha-dependent phosphorylation of p53 in response to DNA methylator damage
28. K-RAS codon 12 mutation determines the polypoid growth of colorectal cancer
29. Neoplastic progression occurs through mutator p pathways in hyperplastic polyposis of the colorectum
30. Lessons from hereditary colorectal cancer
31. Epidemiology of familial adenomatous polyposis in Sweden: Changes over time and differences in phenotype between mates and females
32. Natural history of ampullary adenoma in familial adenomatous polyposis: Reconfirmation of benign nature during extended surveillance
33. Analysis of masked mutations in familial adenomatous polyposis
34. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps
35. The identical 5′ splice-site acceptor mutation in five attenuated APC families from Newfoundland demonstrates a founder effect
36. APC mutation in the alternatively spliced region of exon 9 associated with late onset familal adenomatous polyposis
37. Notable intrafamilial phenotypic variability in a kindred with familial adenomatous polyposis and an APC mutation in exon 9
38. Biology of the adenomatous polyposis coli tumor suppressor
39. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
40. The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: A new facet to Knudson's two hit hypothesis
41. Alleles of APC modulate the frequency and classes of mutations that lead to colon polyps
42. APC mutations in sporadic colorectal tumors: A mutational hotspot and interdependence of the two-hits
43. Activating SRC mutations in a subset of advanced human colon cancers
44. Loss-of-function mutations in PPAR-gamma
45. Going mad with SMADs
46. Allelic loss of chromosome 18q and prognosis in colorectal cancer
47. Colorectal adenomas in the Lynch syndromes: Results of a colonoscopy screening program
48. Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer)
49. Cancer risk associated with germline DNA mismatch repair gene mutations
50. A common MSH2 mutation in English and North American HNPCC families: Origin, phenotypic expression, and sex specific differences in colorectal cancer
51. Genetic susceptibility to non-polyposis colorectal cancer
52. Mismatch repair defects in cancer
53. Mismatch repair deficiency in phenotypically normal human cells
54. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
55. Biallelic inactivation of hMLH1 by epigenetic silencing a novel mechanism causing human MSI cancers
56. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
57. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principle involvement of hMLH1
58. Genomic instability and target gene mutations in colon cancer with different degrees of allelic shifts
59. Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer
60. Interval cancers in hereditary nonpolyposis colorectal cancer
61. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumors
62. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
63. Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability
64. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability
65. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers
66. Missense mutations in hMLH1 associated with colorectal cancer
67. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis
68. Genomic instability in colorectal cancer: Relation to clinicopathologic variables and family history
69. Clinical and pathologic characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellite sequences
70. Association of tumor site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
71. Are there several colorectal cancers?. Epidemiological data
72. Proximal shift of colorectal cancer in the Australian capital territory over 20 years
73. Population risk and physiologic rate parameters for colon cancer. The union of an explicit model for carcinogenesis with the public health records of the United States
74. Menopause and colorectal cancer
75. Sex differences in colorectal cancer mortality in Europe 1955-1996
76. Methylation of the oestrogen receptor CpG island links aging and neoplasia in human colon
77. Aging and DNA methylation in colorectal mucosa and cancer
78. Aberrant CpG-island methylation has non-random and tumor-type-specific patterns
79. Loss of imprinting in normal issue of colorectal cancer patients with microsatellite instability
80. Colon polyps in Beckwith-Wiedemann syndrome: Role of imprinted genes
81. CpG methylation is maintained in human cancer cells lacking DNMT1
82. Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers
83. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells
84. Alterations in DNA methylation in humancolonic neoplasia
85. Folate and carcinogenesis: An integrated scheme
86. Suppression of intestinal neoplasia by DNA hypomethylation